BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8652258)

  • 1. Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer.
    Pedersen L; Zedeler K; Holck S; Schiødt T; Mouridsen HT
    Eur J Cancer; 1995 Dec; 31A(13-14):2289-95. PubMed ID: 8652258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary carcinoma of the breast, prognostic importance of characteristic histopathological features evaluated in a multivariate Cox analysis.
    Pedersen L; Holck S; Schiødt T; Zedeler K; Mouridsen HT
    Eur J Cancer; 1994; 30A(12):1792-7. PubMed ID: 7880608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of DNA content, S-phase fraction, and survival between medullary and ductal carcinoma of the breast.
    Cook DL; Weaver DL
    Am J Clin Pathol; 1995 Jul; 104(1):17-22. PubMed ID: 7611175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medullary carcinoma of the breast, proposal for a new simplified histopathological definition. Based on prognostic observations and observations on inter- and intraobserver variability of 11 histopathological characteristics in 131 breast carcinomas with medullary features.
    Pedersen L; Zedeler K; Holck S; Schiødt T; Mouridsen HT
    Br J Cancer; 1991 Apr; 63(4):591-5. PubMed ID: 2021545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database.
    Wang XX; Jiang YZ; Liu XY; Li JJ; Song CG; Shao ZM
    Oncotarget; 2016 Apr; 7(16):22665-73. PubMed ID: 27009810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance.
    Gaffey MJ; Frierson HF; Mills SE; Boyd JC; Zarbo RJ; Simpson JF; Gross LK; Weiss LM
    Mod Pathol; 1993 Nov; 6(6):721-8. PubMed ID: 8302815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
    Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
    BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria.
    Wargotz ES; Silverberg SG
    Hum Pathol; 1988 Nov; 19(11):1340-6. PubMed ID: 2846422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competing Risk Analyses of Medullary Carcinoma of Breast in Comparison to Infiltrating Ductal Carcinoma.
    Dai D; Shi R; Wang Z; Zhong Y; Shin VY; Jin H; Wang X
    Sci Rep; 2020 Jan; 10(1):560. PubMed ID: 31953417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical medullary carcinoma of the breast has similar prognostic factors and survival to typical medullary breast carcinoma: 3,976 cases from the National Cancer Data Base.
    Mateo AM; Pezzi TA; Sundermeyer M; Kelley CA; Klimberg VS; Pezzi CM
    J Surg Oncol; 2016 Oct; 114(5):533-536. PubMed ID: 27393599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proposal for a new histological classification scheme for predicting short-term tumor recurrence and death in patients with invasive ductal carcinoma of the breast.
    Hasebe T; Imoto S; Sasaki S; Mukai K
    Jpn J Cancer Res; 1998 Dec; 89(12):1358-73. PubMed ID: 10081498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast.
    Rakha EA; Aleskandarany M; El-Sayed ME; Blamey RW; Elston CW; Ellis IO; Lee AH
    Eur J Cancer; 2009 Jul; 45(10):1780-7. PubMed ID: 19286369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis and cell proliferation in medullary carcinoma of the breast: a comparative study between medullary and non-medullary carcinoma using the TUNEL method and immunohistochemistry.
    Kajiwara M; Toyoshima S; Yao T; Tanaka M; Tsuneyoshi M
    J Surg Oncol; 1999 Apr; 70(4):209-16. PubMed ID: 10219015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucinous Carcinoma of the Breast: Clinicopathological Features and Long-term Prognosis in Comparison with Invasive Ductal Cancer; A Single Hospital's 30+-Year Experience.
    Isozaki H; Yamamoto Y; Sakai K; Sho T; Ishihara K; Murakami S; Matsumoto S; Takama T
    Acta Med Okayama; 2020 Apr; 74(2):137-143. PubMed ID: 32341588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotype.
    Orlando L; Renne G; Rocca A; Curigliano G; Colleoni M; Severi G; Peruzzotti G; Cinieri S; Viale G; Sanna G; Goldhirsch A
    Ann Oncol; 2005 Jul; 16(7):1094-9. PubMed ID: 15855225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma.
    Thurman SA; Schnitt SJ; Connolly JL; Gelman R; Silver B; Harris JR; Recht A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):152-9. PubMed ID: 15093911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.
    Cao AY; He M; Liu ZB; Di GH; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2012 Sep; 19(9):3019-27. PubMed ID: 22451233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological characteristics of mucinous carcinoma of the breast in Korea: comparison with invasive ductal carcinoma-not otherwise specified.
    Park S; Koo J; Kim JH; Yang WI; Park BW; Lee KS
    J Korean Med Sci; 2010 Mar; 25(3):361-8. PubMed ID: 20191033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancers with round lumps: correlations between imaging and anatomopathology.
    Larribe M; Thomassin-Piana J; Jalaguier-Coudray A
    Diagn Interv Imaging; 2014 Jan; 95(1):37-46. PubMed ID: 23932764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast.
    Fernández B; Paish EC; Green AR; Lee AH; Macmillan RD; Ellis IO; Rakha EA
    J Clin Pathol; 2011 Nov; 64(11):995-1000. PubMed ID: 21712309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.